Muneharu Yamada Selected Research

Fibrosis (Cirrhosis)

1/2021	TAFRO Syndrome in a Kidney Transplant Recipient That Was Diagnosed on Autopsy: A Case Report.
1/2012	Vascular endothelial cadherin modulates renal interstitial fibrosis.
7/2011	Alteration in the phenotype of macrophages in the repair of renal interstitial fibrosis in mice.
4/2010	Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice.
10/2007	Effects of pioglitazone and candesartan on renal fibrosis and the intrarenal plasmin cascade in spontaneously hypercholesterolemic rats.
3/2007	A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats.
1/2007	Involvement of transglutaminase-2 in pathological changes in renal disease.
8/2005	Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muneharu Yamada Research Topics

Disease

8	Glomerulonephritis 11/2023 - 03/2004
8	Fibrosis (Cirrhosis) 01/2021 - 08/2005
5	Proteinuria 10/2023 - 03/2007
4	IGA Glomerulonephritis (IGA Nephropathy) 11/2023 - 03/2004
4	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2023 - 03/2004
4	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2023 - 01/2021
4	Infections 09/2022 - 01/2022
4	Nephritis 09/2022 - 07/2008
4	Diabetic Nephropathies (Diabetic Nephropathy) 03/2007 - 01/2004
3	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 03/2004
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2023 - 03/2004
2	Disease Progression 05/2023 - 01/2019
2	Inflammation (Inflammations) 09/2022 - 01/2022
2	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 01/2021
2	Peritoneal Fibrosis 01/2022 - 10/2011
2	Ureteral Obstruction 01/2012 - 04/2010
2	Kidney Diseases (Kidney Disease) 10/2007 - 03/2004
1	Renal Insufficiency (Renal Failure) 11/2023
1	Edema (Dropsy) 11/2023
1	Hemoptysis 11/2023
1	Hemorrhage 11/2023
1	COVID-19 11/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Bronchiolitis Obliterans Syndrome 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Hematuria 01/2022
1	Anemia 02/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Monoclonal Gammopathy of Undetermined Significance 01/2021
1	Hyperplasia 01/2021
1	Microscopic Polyangiitis 07/2016
1	Vasculitis (Vasculitides) 07/2016
1	Chronic Renal Insufficiency 04/2010
1	Nephrosclerosis 07/2007
1	Bone Resorption 06/2007
1	Dyslipidemias (Dyslipidemia) 03/2007
1	Obesity 03/2007

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
4	SteroidsIBA 10/2023 - 01/2021
4	plasmin receptorIBA 09/2022 - 07/2008
4	Fibrinolysin FDA Link 09/2022 - 10/2007
4	CreatinineIBA 01/2022 - 01/2007
3	Immunoglobulins (Immunoglobulin)IBA 10/2023 - 01/2021
2	Immunoglobulin G (IgG)IBA 10/2023 - 01/2021
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2021
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2022 - 07/2016
2	Antigen-Antibody Complex (Immune Complex)IBA 12/2022 - 09/2022
2	Peroxidase (Myeloperoxidase)IBA 12/2022 - 07/2016
2	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2022
2	Neuraminidase (Sialidase)IBA 04/2022 - 01/2022
2	antiglomerular basement membrane antibodyIBA 01/2019 - 12/2010
2	candesartanIBA 04/2010 - 10/2007
2	CollagenIBA 04/2010 - 10/2007
2	Pioglitazone (Actos)FDA Link 04/2010 - 10/2007
1	mRNA VaccinesIBA 11/2023
1	Immunoglobulin A (IgA)IBA 11/2023
1	AntibodiesIBA 05/2023
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 09/2022
1	NucleotidesIBA 09/2022
1	AnaphylatoxinsIBA 09/2022
1	Complement System Proteins (Complement)IBA 09/2022
1	Extracellular Matrix ProteinsIBA 09/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 04/2022
1	Thomsen-Friedenreich antigenIBA 04/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	AntistreptolysinIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2021
1	Erythropoietin FDA Link 02/2021
1	Reticulin (Reticular Fiber)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	AutoantibodiesIBA 01/2019
1	Histones (Histone)IBA 07/2016
1	cadherin 5IBA 01/2012
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 10/2011
1	Liposomes (Liposome)IBA 10/2011
1	Clodronic Acid (Clodronate)IBA 10/2011
1	C.I. direct red 80IBA 07/2011
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2010
1	5-(4-phenylbutoxy)psoralenIBA 12/2010
1	PPAR-gamma AgonistsIBA 04/2010
1	Angiotensin Receptor AntagonistsIBA 04/2010
1	salicylhydroxamic acid (SHAM)IBA 04/2010
1	Heymann Nephritis Antigenic ComplexIBA 07/2008
1	Plasminogen Activator Inhibitor 1IBA 10/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2007
1	Antihypertensive Agents (Antihypertensives)IBA 07/2007
1	collagen type I trimeric cross-linked peptideIBA 06/2007
1	Collagen Type I (Type I Collagen)IBA 06/2007
1	AdiponectinIBA 03/2007
1	fasudil (AT 877)IBA 03/2007

Therapy/Procedure

3	Therapeutics 12/2021 - 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2023
1	Peritoneal Dialysis 01/2022
1	Tonsillectomy 12/2021
1	Transplantation 02/2021
1	Blood Transfusion (Blood Transfusions) 02/2021
1	Plasmapheresis 01/2021
1	Oral Administration 10/2007